Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 355

The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.

Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome

Open access
Kim, Bhumsoo, Feldman, Eva L·2015·Experimental & Molecular Medicine

Abstract

Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors that includes obesity, diabetes, and dyslipidemia. Accumulating evidence implies that MetS contributes to the development and progression of Alzheimer’s disease (AD); however, the factors connecting this association have not been determined. Insulin resistance (IR) is at the core of MetS and likely represent the key link between MetS and AD. In the central nervous system, insulin plays key roles in learning and memory, and AD patients exhibit impaired insulin signaling that is similar to that observed in MetS. As we face an alarming increase in obesity and T2D in all age groups, understanding the relationship between MetS and AD is vital for the identification of potential therapeutic targets. Recently, several diabetes therapies that enhance insulin signaling are being tested for a potential therapeutic benefit in AD and dementia. In this review, we will discuss MetS as a risk factor for AD, focusing on IR and the recent progress and future directions of insulin-based therapies. Mounting evidences suggest a strong link between Alzheimer's disease and insulin resistance associated with the metabolic syndrome. The hormone insulin is best known for managing blood sugar levels but it also regulates numerous brain functions. The review by Bhumsoo Kim and Eva Feldman at the University of Michigan in the USA suggets that abnormalities in insulin signaling is intimately connected with the neurodegeneration and dementia seen in Alzheimer's disease. Individuals with type 2 diabetes, or exhibiting obesity and abnormal blood lipid levels that precede diabetes, are at a considerably greater risk of Alzheimer's disease. Disrupted insulin signaling appears to actively promote the accumulation of the toxic protein clumps that are primary hallmarks of this neurological disorder. The authors suggest that interventions that target insulin pathways will slow the progression of Alzheimer's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emm.2015.3

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 355

Metadata

Authors
Kim, B., & Feldman, E. L.
Venue
Experimental & Molecular Medicine
Published
2015-03-13
Volume
47
Issue
3
Pages
e149-e149
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W2034340220
Cited by
355
References
155
FWCI
20.88
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.